Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002230843 | SCV000555942 | likely benign | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313192 | SCV000738482 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001613298 | SCV001841501 | likely benign | not provided | 2019-06-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001613298 | SCV004562243 | likely benign | not provided | 2023-04-03 | criteria provided, single submitter | clinical testing |